Evidence map›Paper›PMID 31809366›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2020

Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use.

Melissa Crawford, Jean van Wyk, Michael Aboud, Vani Vannappagari, Beth Romach, Lloyd Curtis, Brian Wynne, Annemiek de Ruiter, Kimberly Smith, Nassrin Payvandi

Abstract readLetter
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Melissa CrawfordGlaxoSmithKline, Stockley Park, United Kingdom.
Jean van WykViiV Healthcare, Brentford, United Kingdom; and.
Michael AboudViiV Healthcare, Brentford, United Kingdom; and.
Vani VannappagariViiV Healthcare, Research Triangle Park, NC.
Beth RomachViiV Healthcare, Research Triangle Park, NC.
Lloyd CurtisGlaxoSmithKline, Stockley Park, United Kingdom.
Brian WynneViiV Healthcare, Research Triangle Park, NC.
Annemiek de RuiterViiV Healthcare, Brentford, United Kingdom; and.
Kimberly SmithViiV Healthcare, Research Triangle Park, NC.
Nassrin PayvandiViiV Healthcare, Brentford, United Kingdom; and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Product Surveillance, PostmarketingDolutegravirDrug CombinationsFemaleHeterocyclic Compounds, 3-RingHIV InfectionsHIV Integrase InhibitorsHumansOxazinesPiperazinesPregnancyPregnancy Complications, InfectiousPyridonesDolutegravirDrug CombinationsHeterocyclic Compounds, 3-RingHIV Integrase InhibitorsOxazinesPiperazinesPyridones

Identifiers

PMID31809366
PMCPMC6903324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.